{"id":50199,"date":"2022-10-28T00:02:19","date_gmt":"2022-10-27T22:02:19","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/"},"modified":"2022-10-28T00:02:19","modified_gmt":"2022-10-27T22:02:19","slug":"movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/","title":{"rendered":"Movember Launches First of its Kind Clinical Guidelines Driving Excellence in Sexual Health Care in Prostate Cancer"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\nPublication of new guidelines in <i>The Journal of Sexual Medicine<\/i> represents a significant \u2018moment of change\u2019 in prostate cancer care, where sexual dysfunction is the most reported health-related quality of life outcome and greatest unmet need\n<\/li>\n<li>\nThe evidence and clinical expertise-based, biopsychosocial framework, authored by an international expert panel, has been informed by 25 years of scientific research and the expert perspectives of 37 clinicians, researchers and prostate cancer survivors and their partners\n<\/li>\n<li>\nThe guidelines promote openness and inclusivity, encouraging healthcare professionals to consider cultural context and provide tailored care to enhance sexual health and quality of life for every patient\n<\/li>\n<\/ul>\n<p>MELBOURNE, Australia&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/CancerCare?src=hash\" target=\"_blank\" rel=\"noopener\">#CancerCare<\/a>&#8211;New clinical practice guidelines were launched today, generated through the collaboration of a 37-member international panel of experts across 14 countries with analysis of 25 years of scientific research, which has led to the introduction of a new standard of excellence for sexual health care in prostate cancer.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221027005997\/en\/1616959\/5\/movember.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221027005997\/en\/1616959\/21\/movember.jpg\"><\/a><\/p>\n<p>\nThe <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.movember.com%2Fsexualhealthguideline&amp;esheet=52954789&amp;newsitemid=20221027005997&amp;lan=en-US&amp;anchor=Guidelines+for+Sexual+Health+Care+for+Prostate+Cancer+Patients%3A+Recommendations+of+an+International+Panel&amp;index=1&amp;md5=1ccf55ba14465e5d4672bd85eff3c1b5\" rel=\"nofollow noopener\" shape=\"rect\">Guidelines for Sexual Health Care for Prostate Cancer Patients: Recommendations of an International Panel<\/a> provide a first of its kind evidence and expert opinion-based framework that is inclusive for all prostate cancer survivors who have undertaken treatment and their partners. Published following a thorough peer review process in <i>The Journal of Sexual Medicine <\/i>and developed with support from the leading men\u2019s health charity Movember, the guidelines will support clinicians to assess and manage the sexual side effects of prostate cancer therapies and facilitate shared decision-making between clinicians, patients and their partners.\n<\/p>\n<p>\nProstate cancer therapies can negatively impact patients\u2019 sexual function; this can lead to changes in their relationship with their partner and remains the most reported unmet care need. Reliable information or support is not always available, contributing to distress and relationship breakdowns.\n<\/p>\n<p>\nLead Guidelines Author, Daniela Wittmann, PhD, MSW, Certified Sex Therapist and Associate Professor, Department of Urology, University of Michigan, said: \u201c<i>These guidelines were informed not only by evidence, but also by listening to people with prostate cancer and their partners. Addressing sexual health is the responsibility of every clinician of every discipline who touches the life of a prostate cancer patient. Now we have an inclusive roadmap that will allow healthcare providers to address the needs of their patients. By understanding the fact that many prostate cancer patients live long lives, some with partners, requires us to help protect and enhance the quality of their lives in survivorship. By including sexual health as a part of usual care, we will be responding to significant unmet needs and achieve a new standard of care.<\/i>\u201d\n<\/p>\n<p>\nAcross the world, 1.4 million men are diagnosed with prostate cancer each year, with almost 10 million living with or beyond the disease.<sup>1<\/sup> Through a global collaboration of sexual health clinicians, researchers, physicians, nurses, psychologists, physical therapists, social workers, and prostate cancer survivors and their partners, 47 statements and recommendations provide clinicians with a framework to address sexual health challenges in prostate cancer. The framework aims to summarise the evidence, enable clinicians to empower patients and increase their preparedness to initiate sensitive conversations about sexual concerns. Through a biopsychosocial perspective, the guidelines emphasise the importance of tailoring counselling to the cultural, ethnic, racial, sexual and gender needs of individual prostate cancer patients and their partners.\n<\/p>\n<p>\nKellie Paich, MPH, Global Director, Clinical Quality and Survivorship at Movember, said: <i>\u201cHistorically the delivery of sexual health care services for people with prostate cancer has been neither sufficient nor inclusive. Understanding how societal and cultural norms, help-seeking behaviours and the social determinants of health may influence an individual person &#8212; or an entire community &#8212; is essential to understanding how to shape their care.\u201d<\/i>\n<\/p>\n<p>\n<i>\u201cMovember takes our responsibility to be the voice of those we serve seriously. We know that sex remains an important part of life for many people living with prostate cancer and their partners, regardless of race, ethnicity, sexual preference or gender identity. By uniting healthcare professionals to provide comprehensive, inclusive, multi-disciplinary care, we can begin to transform sexual health care in prostate cancer.\u201d<\/i>\n<\/p>\n<p class=\"bwalignc\">\n<b>-ends-<\/b>\n<\/p>\n<p>\n<b>About Guidelines for Sexual Health Care for Prostate Cancer Patients: Recommendations by an International Panel<\/b>\n<\/p>\n<p>\nInformed by 25 years of scientific literature and research, the guidelines provide an evidence and expert opinion-based framework for sexual health care in prostate cancer. The framework helps clinicians to assess and manage the sexual side effects of prostate cancer therapies, facilitate shared decision-making, and increase their preparedness to initiate sensitive, inclusive conversations about sexual concerns with prostate cancer patients and their partners.\n<\/p>\n<p>\nThe guidelines were created through the collaboration of an international panel of 37 sexual health clinicians, researchers, physicians, nurses, psychologists, physical therapists, social workers, and prostate cancer survivors and their partners. They were created in the context of Movember\u2019s ongoing work in the area of sexual health and wellbeing for men living with prostate cancer.\n<\/p>\n<p>\nThe guidelines were first published online in the Journal of Sexual Medicine in September 2022 and were published fully in October. To read the guidelines in full, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.movember.com%2Fsexualhealthguideline&amp;esheet=52954789&amp;newsitemid=20221027005997&amp;lan=en-US&amp;anchor=Movember.com%2Fsexualhealthguideline&amp;index=2&amp;md5=bde7c49b65cf1748b2e64527d205bde4\" rel=\"nofollow noopener\" shape=\"rect\">Movember.com\/sexualhealthguideline<\/a>.\n<\/p>\n<p>\n<b>About Movember<\/b>\n<\/p>\n<p>\nMovember is the leading global charity changing the face of men\u2019s health. We exist to stop men dying too young by tackling some of the most complex health issues facing men today \u2013 mental health, suicide, prostate cancer and testicular cancer.\n<\/p>\n<p>\nWhat started as a single-minded fundraising and awareness campaign in 2003 has evolved into a multi-faceted health organisation with programs accessed by millions worldwide.\n<\/p>\n<p>\nWith global support from our Mo Bros, Mo Sisters and Mo community, Movember funds and delivers biomedical research, cancer survivorship programs, innovative community mental health programs and digital health products that work for men.\n<\/p>\n<p>\nTo find out more about the important work Movember are doing to support the prostate cancer community, visit the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftruenorth.movember.com%2Fen-gb&amp;esheet=52954789&amp;newsitemid=20221027005997&amp;lan=en-US&amp;anchor=Movember+True+North+Website&amp;index=3&amp;md5=3fedc01b5cb92c2ed95dc4d5b4c3a69e\" rel=\"nofollow noopener\" shape=\"rect\">Movember True North Website<\/a>. True North is a global prostate cancer programme, proudly funded by Movember, that aims support and guide people living with prostate cancer through every step of their journey.\n<\/p>\n<p>\n<b>References<\/b>\n<\/p>\n<p>\n<sup>1<\/sup> Data Source: Global Burden of Disease, Date Accessed: 2021-11-29, Dataset Name: NA, Data Source Link: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fghdx.healthdata.org%2Fgbd-results-tool&amp;esheet=52954789&amp;newsitemid=20221027005997&amp;lan=en-US&amp;anchor=http%3A%2F%2Fghdx.healthdata.org%2Fgbd-results-tool&amp;index=4&amp;md5=670851e00b63975c9cc8e9907af51881\" rel=\"nofollow noopener\" shape=\"rect\">http:\/\/ghdx.healthdata.org\/gbd-results-tool<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Notes to Editor:<\/b>\n<\/p>\n<p>\nMedia contacts:<br \/>\n<br \/>Amy O\u2019Connor<br \/>\n<br \/>Senior Lead, Social Impact Campaigns, Movember<br \/>\n<br \/>E: <a target=\"_blank\" href=\"&#x6d;&#x61;&#105;&#108;to&#x3a;&#x61;&#x6d;&#121;&#46;o&#x63;&#x6f;&#x6e;&#110;&#111;r&#x40;&#x6d;&#x6f;&#118;&#101;m&#x62;&#x65;&#x72;&#46;&#99;om\" rel=\"nofollow noopener\" shape=\"rect\">&#97;&#x6d;&#121;&#x2e;&#111;&#x63;&#111;&#x6e;n&#x6f;r&#x40;m&#x6f;v&#101;&#x6d;&#98;&#x65;&#114;&#x2e;&#99;&#x6f;&#109;<\/a>\n<\/p>\n<p>\nNathan McGlone<br \/>\n<br \/>Senior Account Director, Aurora Healthcare Communications<br \/>\n<br \/>E: <a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x6d;&#111;&#x76;&#101;&#x6d;&#98;&#x65;&#114;&#x40;&#97;&#x75;&#114;&#x6f;&#114;&#x61;&#99;&#x6f;&#109;&#x6d;s&#x2e;c&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x6d;&#x6f;&#x76;&#x65;&#x6d;&#x62;&#101;&#114;&#64;&#97;uror&#x61;&#x63;&#x6f;&#x6d;&#x6d;&#x73;&#46;&#99;&#111;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Publication of new guidelines in The Journal of Sexual Medicine represents a significant \u2018moment of change\u2019 in prostate cancer care, where sexual dysfunction is the most reported health-related quality of life outcome and greatest unmet need The evidence and clinical expertise-based, biopsychosocial framework, authored by an international expert panel, has been informed by 25 years &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50199","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Movember Launches First of its Kind Clinical Guidelines Driving Excellence in Sexual Health Care in Prostate Cancer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Movember Launches First of its Kind Clinical Guidelines Driving Excellence in Sexual Health Care in Prostate Cancer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Publication of new guidelines in The Journal of Sexual Medicine represents a significant \u2018moment of change\u2019 in prostate cancer care, where sexual dysfunction is the most reported health-related quality of life outcome and greatest unmet need The evidence and clinical expertise-based, biopsychosocial framework, authored by an international expert panel, has been informed by 25 years ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-27T22:02:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221027005997\/en\/1616959\/21\/movember.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Movember Launches First of its Kind Clinical Guidelines Driving Excellence in Sexual Health Care in Prostate Cancer\",\"datePublished\":\"2022-10-27T22:02:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\\\/\"},\"wordCount\":1044,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221027005997\\\/en\\\/1616959\\\/21\\\/movember.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\\\/\",\"name\":\"Movember Launches First of its Kind Clinical Guidelines Driving Excellence in Sexual Health Care in Prostate Cancer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221027005997\\\/en\\\/1616959\\\/21\\\/movember.jpg\",\"datePublished\":\"2022-10-27T22:02:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221027005997\\\/en\\\/1616959\\\/21\\\/movember.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221027005997\\\/en\\\/1616959\\\/21\\\/movember.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Movember Launches First of its Kind Clinical Guidelines Driving Excellence in Sexual Health Care in Prostate Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Movember Launches First of its Kind Clinical Guidelines Driving Excellence in Sexual Health Care in Prostate Cancer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/","og_locale":"en_US","og_type":"article","og_title":"Movember Launches First of its Kind Clinical Guidelines Driving Excellence in Sexual Health Care in Prostate Cancer - Pharma Trend","og_description":"Publication of new guidelines in The Journal of Sexual Medicine represents a significant \u2018moment of change\u2019 in prostate cancer care, where sexual dysfunction is the most reported health-related quality of life outcome and greatest unmet need The evidence and clinical expertise-based, biopsychosocial framework, authored by an international expert panel, has been informed by 25 years ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-27T22:02:19+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221027005997\/en\/1616959\/21\/movember.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Movember Launches First of its Kind Clinical Guidelines Driving Excellence in Sexual Health Care in Prostate Cancer","datePublished":"2022-10-27T22:02:19+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/"},"wordCount":1044,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221027005997\/en\/1616959\/21\/movember.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/","url":"https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/","name":"Movember Launches First of its Kind Clinical Guidelines Driving Excellence in Sexual Health Care in Prostate Cancer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221027005997\/en\/1616959\/21\/movember.jpg","datePublished":"2022-10-27T22:02:19+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221027005997\/en\/1616959\/21\/movember.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221027005997\/en\/1616959\/21\/movember.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/movember-launches-first-of-its-kind-clinical-guidelines-driving-excellence-in-sexual-health-care-in-prostate-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Movember Launches First of its Kind Clinical Guidelines Driving Excellence in Sexual Health Care in Prostate Cancer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50199"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50199\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50199"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50199"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}